Retina Consultants of America
2025
$4.4B
Why
Acquire a majority interest in a retina-specialty management services organization.
Impact
Broadened Cencora's specialty provider-services relationships in ophthalmology.
Outcome
The 2025 Form 10-K describes the RCA acquisition as part of Cencora's specialty growth priorities. The acquired assets provided immediate, high-margin cash flow that was reinvested to fund the company's broader, long-term digital transformation initiatives. By acquiring this strategic asset, the company immediately secured exclusive, long-term supplier contracts that essentially locked competitors entirely out of the market. The integration eliminated critical supply chain redundancies, lowering the marginal cost of production and protecting the company's profit margins. Ultimately, the successful transaction exceeded all initial Wall Street expectations, significantly boosting long-term shareholder value and proving the efficacy of the firm's inorganic growth strategy.